Suppr超能文献

[雷替泊尔对血液凝固系统的作用]

[Action of ratibol on the blood coagulation system].

作者信息

Seĭfulla R D, Vaĭsberg M A, Syrov V N

出版信息

Farmakol Toksikol. 1986 Jul-Aug;49(4):40-2.

PMID:3758326
Abstract

Oral ratibol (10 mg/kg) produced in rabbits a decrease of blood coagulability (increased the time of thromboelastogram reaction, reduced the activity of prothrombin complex according to Quick, tolerance to heparin and activity of factors II, VII, XIII and concentration of factor I). The drug administration (1 mg/kg) for 20 days caused at the first stage a decrease and at the second stage an increase of blood coagulability. At a single and 20-day administration ratibol enhanced the fibrinolytic activity, reduced the resistance of fibrin clot to streptokinase and increased the antithrombin activity.

摘要

口服雷替波尔(10毫克/千克)可使家兔血液凝固性降低(血栓弹力图反应时间延长,根据奎克法测定的凝血酶原复合物活性降低,对肝素的耐受性以及因子II、VII、XIII的活性和因子I的浓度降低)。给药20天(1毫克/千克),第一阶段会导致血液凝固性降低,第二阶段则会使其升高。单次给药及连续给药20天,雷替波尔均可增强纤溶活性,降低纤维蛋白凝块对链激酶的抵抗力,并提高抗凝血酶活性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验